Original Research
Accepted on 10 Feb 2026
Disproportionality Analysis of Adverse Events Associated with Endothelin Receptor Antagonists Based on the FDA Adverse Event Reporting System (FAERS)
in Cardiovascular Pharmacology and Drug Discovery
- 147 views